Downregulation of p27(KIP1) and Ki67/Mib1 labeling index support the classification of thyroid carcinoma into prognostically relevant categories

American Journal of Surgical Pathology

Volumn 23, Issue 6, 1999, Pages 678-685

  Tallini, G ^b,c   Garcia Rostan, G ^b   Herrero, A ^d   Zelterman, D ^b   Viale, G ^a   Bosari, S ^a   Carcangiu, M L ^b  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b YALE UNIVERSITY   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Department of Pathology Yale University School of Medicine ^*

Author keywords

Carcinoma; Cellular proliferation; Ki67 Mib1; P27(KIP1); Thyroid; Tumor classification; Tumor differentiation

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; KI 67 ANTIGEN; PROTEIN P27; TUMOR MARKER; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR 1B; MICROTUBULE ASSOCIATED PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CELL PROLIFERATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PROGNOSIS; THYROID CARCINOMA; TUMOR DIFFERENTIATION; TUMOR VOLUME; ADENOCARCINOMA; CLASSIFICATION; DISEASE FREE SURVIVAL; DOWN REGULATION; DRUG ANTAGONISM; ENZYME IMMUNOASSAY; METABOLISM; MIDDLE AGED; PAPILLARY CARCINOMA; PATHOLOGY; THYROID TUMOR;

ADENOCARCINOMA, FOLLICULAR; ADULT; AGED; CARCINOMA, PAPILLARY; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; DISEASE-FREE SURVIVAL; DOWN-REGULATION; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; PROGNOSIS; THYROID NEOPLASMS; TUMOR SUPPRESSOR PROTEINS;

EID: 0032587780     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-199906000-00007     Document Type: Article

References (48)

1. Bacus S, Flowers JL, Press MF, Bacus JW, McCarty KS. The evaluation of estrogen receptor in primary breast carcinoma by computer-assisted image analysis. Am J Clin Pathol 1988;90: 233-9.
2. Bronner MP, LiVolsi VA. Spindle cell squamous carcinoma of the thyroid: an unusual anaplastic tumor associated with tall cell papillary cancer. Mod Pathol 1991;4:637-43.
3. Carcangiu ML, Zampi G, Rosai J. Poorly differentiated ('insular') thyroid carcinoma. A reinterpretation of Langhans' 'wuchernde struma.' Am J Surg Pathol 1984;8:655-68.
4. Carr K, Heffess C, Jin L, Lloyd RV. Immunohistochemical analysis of thyroid carcinomas utilizing antibodies to p53 and Ki-67. Appl Immunohistochem 1993;1:201-7.
5. Kip1. Genes Dev 1997;11:2335-46.
6. Kip1 protein: prognostic implications in primary breast cancer. Nature Med 1997;3:227-30.
7. Cordon-Cardo C. Mutation of cell cycle regulators: biological and clinical implications for human neoplasia. Am J Pathol 1995;147: 545-60.
8. cip1/waf1 in differentiation of primary mouse keratinocytes independent of cell cycle control. Science 1998;280:1069-72.
9. Kip1 and the timing of oligodendrocyte differentiation. EMBO J 1997;16:306-17.
10. Kip1 and Ki-67 in benign and malignant thyroid tumors. Mod Pathol 1998;11:169-74.
11. Esposito V, Baldi A, DeLuca A, et al. Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer. Cancer Res 1997;57:3381-5.
12. Flint A, Davenport RD, Lloyd RV. The tall cell variant of papillary carcinoma of the thyroid gland: comparison with the common form of papillary carcinoma by DNA and morphometric analysis. Arch Pathol Lab Med 1991;115:169-71.
13. Flynn SD, Forman BH, Stewart AF, Kinder BK. Poorly differentiated ('insular') carcinoma of the thyroid gland: an aggressive subset of differentiated thyroid neoplasms. Surgery 1988;104:963-70.
14. Fredersdorf S, Burns J, Milne AM, et al. High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers. Proc Natl Acad Sci USA 1997;94:6380-5.
15. Hawk WA, Hazard JB. The many appearances of papillary carcinoma of the thyroid. Comparison with the common form of papillary carcinoma by DNA and morphometric analysis. Cleve Clin Q 1976;43:207-16.
16. Hedinger C, Williams ED, Sobin LH. Histological typing of thyroid tumours, 2nd ed. Berlin: Springer-Verlag, 1988.
17. Jacks T, Weinberg RA. The expanding role of cell cycle regulators. Science 1998;280:1035-6.
18. Johnson TL, Lloyd RV, Thompson NW, Beirwaltes WH, Sisson JC. Prognostic implications of the tall cell variant of papillary thyroid carcinoma. Am J Surg Pathol 1988;12:22-7.
19. Kip1 expression in papillary thyroid carcinomas. Endocr Pathol 1997;8:293-300.
20. Kip1 expression in endocrine and other tumors. Am J Pathol 1997;150:401-7.
21. Loda M, Cukor B, Tam SW, et al. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nature Med 1997;3:231-4.
22. Mizukami Y, Nonomura A, Michigishi T, Noguchi M, Ohmura K, Nakamura S, Hoso M. Poorly differentiated ('insular') carcinoma of the thyroid. Pathol Int 1995;45:663-8.
23. Moreno Egea A, Rodriguez Gonzalez JM, Sola Perez J, Soria Cogollos T, Parilla Paricio P. Prognostic value of the tall cell variety of papillary cancer of the thyroid. Eur J Surg Oncol 1993; 19:517-21.
24. Morgan DO. Principles of CDK regulation. Nature 1995;374: 131-4.
25. Mori M, Mimori K, Shiraishi T, Tanaka S, Ueo H, Sugimachi K, Akiyoshi T. p27 expression and gastric carcinoma. Nature Med 1997;3:593.
26. Pagano M, Tam SW, Theodoras AM, et al. Role of ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 1995;269:682-5.
27. Papotti M, Botto Micca F, Favero A, Palestini N, Bussolati G. Poorly differentiated thyroid carcinomas with primordial cell component: a group of aggressive lesions sharing insular, trabecular, and solid patterns. Am J Surg Pathol 1993;17:291-301.
28. Papotti M, Torchio B, Grassi L, Favero A, Bussolati G. Poorly differentiated oxyphilic (Hurthle cell) carcinomas of the thyroid. Am J Surg Pathol 1996;20:686-94.
29. Pilotti S, Collini P, Manzari A, Marubini E, Rilke F. Poorly differentiated forms of papillary thyroid carcinoma: distinctive entities or morphological patterns? Sem Diagn Pathol 1995;12:249-55.
30. Ponce-Castaneda MV, Lee M-H, Latres E, et al. p27 Kip1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumours. Cancer Res 1995;55:1211-4.
31. Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nature Med 1997;3:222-5.
32. Rosai J, Carcangiu ML, DeLellis RA. Tumors of the thyroid gland. In: Atlas of Tumor Pathology, 3rd series, fascicle 5. Washington: Armed forces Institute of Pathology, 1992.
33. Sakamoto A, Kasai N, Sugano H. Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high-risk group of papillary and follicular carcinomas. Cancer 1983;52:1849-55.
34. Sasaki A, Tsutomu D, Kashima K, Yokoyama S, Nakayama I, Noguchi S. Insular component as a risk factor of thyroid carcinoma. Pathol Int 1996;46:939-46.
35. Sherr CJ. G1 phase progression: cycling on cue. Cell 1994;79: 551-5.
36. Sherr CJ, Roberts JM. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 1995;9:1149-63.
37. Sherr CJ. Cancer cell cycle. Science 1996;274:1672-7.
38. Singh SP, Lipman J, Goldman H, et al. Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma. Cancer Res 1998;58:1730-5.
39. Soares P, Sobrinho-Simoes M. Recent advances in cytometry, cytogenetics and molecular genetics of thyroid tumours and tumour-like lesions. Path Res Pract 1995;191:304-17.
40. Sobrinho-Simoes M, Nesland JM, Johannessen JV. Columnar-cell carcinoma. Another variant of poorly differentiated carcinoma of the thyroid. Am J Clin Pathol 1988;89:264-7.
41. Sobrinho-Simoes M, Sambade C, Nesland JM, Johannessen JV. Tall cell papillary carcinoma. Am J Surg Pathol 1989;13:79-80.
42. Sobrinho-Simoes M. Poorly differentiated carcinomas of the thyroid. Endocr Pathol 1996;7:99-102.
43. Tan P, Cady B, Wanner M, et al. The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas. Cancer Res 1997;57:1259-63.
44. Terry JH, St. John SA, Karkowski FJ, Suarez JR, Yassa NH, Platica CD, Marti JR. Tall cell papillary thyroid cancer: incidence and prognosis. Am J Surg 1994;168:459-61.
45. kip1 is a novel prognostic factor in localized human prostate adenocarcinoma. Cancer Res 1998;58:542-8.
46. van den Brekel MWM, Hekkenberg RJ, Asa SL, Tomlinson G, Rosen IB, Freeman JL. Prognostic features in tall cell papillary carcinoma and insular thyroid carcinoma. Laryngoscope 1997;107: 254-9.
47. Van der Laan BFAM, Freeman JL, Tsang RW, Asa SL. The association of well-differentiated thyroid carcinoma with insular of anaplastic thyroid carcinoma: evidence for dedifferentiation in tumor progression. Endocr Pathol 1993;4:215-21.
48. Yang RM, Naitoh J, Murphy M, Wang HJ, Phillipson J, deKernion JB, Loda M, Reiter RE. Low p27 expression predicts poor disease-free survival in patients with prostate cancer. J Urol 1998;159: 941-945.